Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia

Peter F. Buckley; Brian J. Miller; Anilkumar Pillai; Brian Kirkpatrick

doi:10.1016/j.schres.2014.06.030

Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia

Peter F. Buckley, Brian J. Miller, Anilkumar Pillai, Brian Kirkpatrick

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	268-269
Number of pages	2
Journal	Schizophrenia Research
Volume	158
Issue number	1-3
DOIs	https://doi.org/10.1016/j.schres.2014.06.030
State	Published - 2014

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.schres.2014.06.030

Cite this

@article{50ae93a3209944beabd640da0c157244,

title = "Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia",

author = "Buckley, {Peter F.} and Miller, {Brian J.} and Anilkumar Pillai and Brian Kirkpatrick",

note = "Funding Information: In the past 12 months, Dr. Miller has received grant/research support from the National Institute of Mental Health (NIMH), the American Psychiatric Association , and Georgia Regents University ; and honoraria from Medscape and Insight Consulting Group . ",

year = "2014",

doi = "10.1016/j.schres.2014.06.030",

language = "English (US)",

volume = "158",

pages = "268--269",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier",

number = "1-3",

}

TY - JOUR

T1 - Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia

AU - Buckley, Peter F.

AU - Miller, Brian J.

AU - Pillai, Anilkumar

AU - Kirkpatrick, Brian

N1 - Funding Information: In the past 12 months, Dr. Miller has received grant/research support from the National Institute of Mental Health (NIMH), the American Psychiatric Association , and Georgia Regents University ; and honoraria from Medscape and Insight Consulting Group .

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84906933819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906933819&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2014.06.030

DO - 10.1016/j.schres.2014.06.030

M3 - Letter

C2 - 25052781

AN - SCOPUS:84906933819

SN - 0920-9964

VL - 158

SP - 268

EP - 269

JO - Schizophrenia Research

JF - Schizophrenia Research

IS - 1-3

ER -

Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this